title: Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients.
abstract: Our results suggest that bezafibrate may be useful in the treatment of high Lp(a) levels in heart transplant patients.
authors.affiliation: Unidad de Lipidos y Arteriosclerosis, Hospital Universitario Reina Sofia, Cordoba, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Perez-Jimenez
authors.forename: L
authors.initials: L
authors.lastname: Hidalgo
authors.forename: J L
authors.initials: JL
authors.lastname: Zambrana
authors.forename: J M
authors.initials: JM
authors.lastname: Arizon
authors.forename: J A
authors.initials: JA
authors.lastname: Jimenez-Pereperez
authors.forename: M
authors.initials: M
authors.lastname: Concha
authors.forename: A
authors.initials: A
authors.lastname: Espino
authors.forename: J
authors.initials: J
authors.lastname: Blanco
authors.forename: F
authors.initials: F
authors.lastname: Valles
authors.forename: J
authors.initials: J
authors.lastname: Lopez-Miranda
mesh_terms: D001629:Bezafibrate / Q000494:pharmacology*; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood / Q000187:drug effects*; D008148:Lovastatin / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D008055:Lipids; D017270:Lipoprotein(a); D008148:Lovastatin; D001629:Bezafibrate